SCHEMBL13030992

SCHEMBL13030992

C[C@H]1C[C@]2(CCN1C(=O)OCc1ccccc1)C(=N)NC(=O)N2c1cccc(C#N)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCHR1 Q99705 4/20 0.41
HTR2C P28335 2/20 0.39
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM4 P08173 1/20 0.38
HTR1A P08908 1/20 0.37
ADORA3 P0DMS8 1/20 0.37
OPRK1 P41145 1/20 0.37
SLC6A3 Q01959 1/20 0.37
ELANE P08246 1/20 0.36
PDK1 Q15118 1/20 0.36
PDK2 Q15119 1/20 0.36
PDK3 Q15120 1/20 0.36
PDK4 Q16654 1/20 0.36
OPRM1 P35372 1/20 0.36
KCNH2 Q12809 1/20 0.36
SIGMAR1 Q99720 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.36
MGLL Q99685 1/20 0.35
ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13030986 0.92 MCHR1 (0.48) MCHR1HTR2CCHRM2CHRM1CHRM4
SCHEMBL10262712 0.88 BACE1 (0.43) HTR2CHTR1AADORA3OPRK1SLC6A3
SCHEMBL755093 0.88 BACE1 (0.43) HTR2CHTR1AADORA3OPRK1SLC6A3
SCHEMBL3479505 0.86 MCHR1 (0.41) MCHR1CHRM2CHRM1OPRM1KCNH2
SCHEMBL3479604 0.77 MCHR1 (0.48) MCHR1CHRM2CHRM1OPRM1KCNH2
SCHEMBL8250662 0.76 BACE1 (0.33) HTR2COPRK1OPRM1ALDH1A1SMN1; SMN2
SCHEMBL8252600 0.76 BACE1 (0.33) HTR2COPRK1OPRM1ALDH1A1SMN1; SMN2
SCHEMBL2435120 0.73 PDK1 (0.40) HTR2CHTR1AADORA3OPRK1SLC6A3
SCHEMBL14315421 0.73 PDK1 (0.40) HTR2CHTR1AADORA3OPRK1SLC6A3
SCHEMBL4734282 0.73 BACE1 (0.41) OPRK1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298342-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease MERCK & CO., INC. (US) 2010-11-25 US disclosed
US-20100298342-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease MERCK & CO., INC. (US) 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298342-A1 Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease BACE1, APP, PSEN1 MCHR1 4417/4885HTR2C 2501/4885CHRM2 2442/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.